Abbott Laboratories vs. Savara Inc.
Abbott Laboratories and Savara Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | SVRA | |
|---|---|---|
| Market Cap | $174.89 billion | $1.04 billion |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | $-139,309,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | SVRA | |
|---|---|---|
| P/E Ratio | 32.78 | — |
| Price / Book | 3.38 | -1950.72 |
| Price / Sales | 3.75 | — |
SVRA leads on 1 of 1 valuation factors.
Profitability
| ABT | SVRA | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | 26087.83% |
SVRA leads on 1 of 1 profitability factors.
Dividend
| ABT | SVRA | |
|---|---|---|
| Dividend Yield | 2.49% | — |
| Payout Ratio | 81.55 | — |
ABT and SVRA split the dividend factors evenly.
Risk & Sentiment
| ABT | SVRA | |
|---|---|---|
| Short Interest | 0.57% | 0.16% |
SVRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SVRA overview, SVRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.